ALS motor phenotypes: a revised ‘OPM’ classification

Read full text
Authors: Thomas Meyer, Nicola Ticozzi, Markus Weber, John Ravits, Paul Lingor, Magdalena Kuźma-Kozakiewicz, Matthias Boentert, Torsten Grehl, P. Corcia, Mónica Povedano Panadés, André Maier, Caroline Ingre
+8 more Hakan Cetin, Patrick Weydt, Christian Lunetta, Leonard van den Berg, Albert C. Ludolph, David Brenner, Martin R Turner, Angela Genge
Cited by: 3
References: 30

Abstract

Background Defining motor phenotypes in amyotrophic lateral sclerosis (ALS) is important for individualized care and optimal therapeutic trial design. The “ALS-OPM” classification is based on the onset region (O), the propagation of motor symptoms (P), and the degree of clinical upper (UMN) and/or lower (LMN) motor neuron dysfunction (M).Methods An international ALS expert focus group was held in September 2025, followed by a consensus process through which revisions of the OPM classification were finalized.Results Onset (O1-4) identifies first motor symptoms as relating to the head (O1), distal/proximal arm (O2d/p), respiratory/axial trunk (O3r/a), or distal/proximal leg (O4d/p). Onset symptoms are defined by weakness or slowed, poorly coordinated voluntary movements in the muscles of the head, arm, trunk, or leg, including dysarthria, dysphagia, dysphonia, dyspnea, and axial instability. Propagation (P1(n)) or absence of propagation (P0(n)) of motor symptoms from the onset region to another body region are designated, where n denotes the number of months from onset to propagation or assessment. The degree of UMN dysfunction (slowed, poorly coordinated voluntary movements, hyperreflexia and/or spastic muscle tone, emotional lability) and/or LMN dysfunction (weakness with associated muscle atrophy) is classified as follows: balanced UMN and LMN dysfunction (M0); dominant (M1d) or pure UMN dysfunction (M1p); dominant (M2d) or pure LMN dysfunction (M2p); and dissociated UMN/LMN dysfunction (M3), in which the arms and legs predominantly show LMN and UMN involvement, respectively.Conclusion The revised ALS-OPM classification aims to make it routine, practical and feasible to capture phenotype in clinical practice and therapeutic trials.

Fields of Study & Subjects

Amyotrophic Lateral Sclerosis Research Neurological disorders and treatments Epilepsy research and treatment

Publication details

Journal / source
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Publisher
Informa UK Limited
Volume
27
Issue
5-6
Pages
540–552
Publication date
17 March 2026
Language
EN